Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Sandoz Eyes 2026 Aflibercept Launch With Regeneron Eylea Settlement
Litigation Deal Allows Enzeevu To Reach US Market In Q4 Next Year
Sep 09 2025
•
By
Dave Wallace
Sandoz is looking to launch its Eylea biosimilar in 2026
(Shutterstock)
More from Biosimilars
More from Products